Medicines optimisation is an approach that seeks to maximise the beneficial clinical outcomes for patients from medicines with an emphasis on safety, governance, professional collaboration and patient engagement.
The AWP Medicine Optimisation Group (MOG) is the key management group responsible for ensuring that the Trust is compliant with all aspects of Medicines Optimisation, including statutory obligations in relation to medicines. Its aim is to promote a consistent approach to the cost effective and evidence based use of medicines across the Trust.
MOG meets every other month to discuss formulary issues and prescribing guidance.
The terms of reference, appeals process, agenda and minutes of recent meetings are available below.
Should you wish to see papers prior to the ones available below, please use our request for information form request for information form.